Exagen (XGN) Competitors $3.58 -0.20 (-5.29%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.77 +0.19 (+5.42%) As of 02/21/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends XGN vs. AIRS, VMD, LFMD, SERA, BDSX, QIPT, EUDA, TOI, PIII, and BNRShould you be buying Exagen stock or one of its competitors? The main competitors of Exagen include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), LifeMD (LFMD), Sera Prognostics (SERA), Biodesix (BDSX), Quipt Home Medical (QIPT), EUDA Health (EUDA), Oncology Institute (TOI), P3 Health Partners (PIII), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry. Exagen vs. AirSculpt Technologies Viemed Healthcare LifeMD Sera Prognostics Biodesix Quipt Home Medical EUDA Health Oncology Institute P3 Health Partners Burning Rock Biotech Exagen (NASDAQ:XGN) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, community ranking, institutional ownership, media sentiment and risk. Which has more risk & volatility, XGN or AIRS? Exagen has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500. Do insiders and institutionals have more ownership in XGN or AIRS? 75.3% of Exagen shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 26.1% of Exagen shares are owned by company insiders. Comparatively, 78.8% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to XGN or AIRS? In the previous week, AirSculpt Technologies had 1 more articles in the media than Exagen. MarketBeat recorded 1 mentions for AirSculpt Technologies and 0 mentions for Exagen. Exagen's average media sentiment score of 0.00 equaled AirSculpt Technologies'average media sentiment score. Company Overall Sentiment Exagen Neutral AirSculpt Technologies Neutral Does the MarketBeat Community favor XGN or AIRS? Exagen received 12 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 57.50% of users gave Exagen an outperform vote while only 36.67% of users gave AirSculpt Technologies an outperform vote. CompanyUnderperformOutperformExagenOutperform Votes2357.50% Underperform Votes1742.50% AirSculpt TechnologiesOutperform Votes1136.67% Underperform Votes1963.33% Is XGN or AIRS more profitable? AirSculpt Technologies has a net margin of -4.13% compared to Exagen's net margin of -30.36%. AirSculpt Technologies' return on equity of 2.22% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-30.36% -92.58% -33.74% AirSculpt Technologies -4.13%2.22%0.90% Do analysts rate XGN or AIRS? Exagen currently has a consensus price target of $7.50, suggesting a potential upside of 109.50%. AirSculpt Technologies has a consensus price target of $5.00, suggesting a potential downside of 6.28%. Given Exagen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Exagen is more favorable than AirSculpt Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00AirSculpt Technologies 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger valuation and earnings, XGN or AIRS? AirSculpt Technologies has higher revenue and earnings than Exagen. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$52.55M1.20-$23.69M-$0.94-3.81AirSculpt Technologies$195.92M1.58-$4.48M-$0.14-38.11 SummaryAirSculpt Technologies beats Exagen on 11 of the 17 factors compared between the two stocks. Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XGN vs. The Competition Export to ExcelMetricExagenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$63.15M$3.11B$5.77B$8.98BDividend YieldN/A20.51%4.78%3.85%P/E Ratio-3.8115.6226.4618.82Price / Sales1.20173.07448.1776.45Price / CashN/A387.2444.0437.47Price / Book2.694.847.634.64Net Income-$23.69M-$22.21M$3.18B$245.69M7 Day Performance-15.37%-4.33%-1.82%-2.63%1 Month Performance-10.72%-0.84%0.22%-2.37%1 Year Performance77.23%13.18%17.49%13.65% Exagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XGNExagen4.3241 of 5 stars$3.58-5.3%$7.50+109.5%+77.2%$66.67M$55.75M-3.81220AIRSAirSculpt Technologies0.2475 of 5 stars$5.45+2.1%$5.00-8.3%-15.2%$315.45M$195.92M-38.93240VMDViemed Healthcare1.8943 of 5 stars$7.91-0.8%N/A-6.9%$308.02M$183.01M29.30630LFMDLifeMD1.5482 of 5 stars$6.89+5.5%$11.14+61.7%-23.3%$298.41M$152.55M-10.77230Insider TradeNews CoverageSERASera Prognostics0.6843 of 5 stars$4.45-2.0%N/A-56.4%$150.28M$310,000.00-4.49120BDSXBiodesix3.3237 of 5 stars$0.95-5.0%$3.06+222.1%-39.6%$138.20M$49.09M-2.44220QIPTQuipt Home Medical2.9673 of 5 stars$3.02+1.7%$6.25+107.0%-43.7%$130.13M$245.91M-20.131,200EUDAEUDA Health0.405 of 5 stars$4.00-8.5%N/A+175.2%$98.52M$3.71M0.002TOIOncology Institute2.5577 of 5 stars$1.00+22.0%$2.50+150.0%-51.6%$75.56M$324.24M-1.28660News CoveragePIIIP3 Health Partners3.3423 of 5 stars$0.20-0.5%$2.38+1,117.3%-80.2%$70.01M$1.27B-0.23500Positive NewsBNRBurning Rock Biotech0.6348 of 5 stars$6.25-3.5%N/A-17.7%$64M$75.70M-2.081,390Gap Up Related Companies and Tools Related Companies AIRS Alternatives VMD Alternatives LFMD Alternatives SERA Alternatives BDSX Alternatives QIPT Alternatives EUDA Alternatives TOI Alternatives PIII Alternatives BNR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XGN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XGN Stock Alerts